Research & Development

国产亚洲网友自拍快讯:恒指低开0.53% 微创医疗、中国通号小幅上涨


  霍去病抓著曹襄的肩膀就把他從籃筐里提出來,頓在地上道︰“你連秋千架都不敢上,誰敢指望你上天。”   這一點只要是長安人都知道。国产   災害遠比雲瑯想象的重。亚洲   直到皇帝將李夫人之子托付阿嬌撫養之後,這樣的傳說才慢慢地消失了。网友自拍   微微嘆了一口氣,無數愁緒就涌上心頭。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo